(Q28295135)

English

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee

scientific article

Statements

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee (English)
0 references
P A Vasey
0 references
S B Kaye
0 references
R Morrison
0 references
C Twelves
0 references
P Wilson
0 references
R Duncan
0 references
A H Thomson
0 references
L S Murray
0 references
T E Hilditch
0 references
T Murray
0 references
S Burtles
0 references
D Fraier
0 references
E Frigerio
0 references
J Cassidy
0 references
January 1999
0 references
5
0 references
1
0 references
83-94
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit